BR112018014769A2 - ?composto, composição farmacêutica, e, método para tratamento do eczema nas mãos? - Google Patents
?composto, composição farmacêutica, e, método para tratamento do eczema nas mãos?Info
- Publication number
- BR112018014769A2 BR112018014769A2 BR112018014769-9A BR112018014769A BR112018014769A2 BR 112018014769 A2 BR112018014769 A2 BR 112018014769A2 BR 112018014769 A BR112018014769 A BR 112018014769A BR 112018014769 A2 BR112018014769 A2 BR 112018014769A2
- Authority
- BR
- Brazil
- Prior art keywords
- hands
- compound
- pharmaceutical composition
- treating eczema
- eczema
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Storage Of Fruits Or Vegetables (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16152215.6 | 2016-01-21 | ||
| EP16152215 | 2016-01-21 | ||
| PCT/EP2017/051133 WO2017125523A1 (en) | 2016-01-21 | 2017-01-20 | Treatment of hand eczema |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018014769A2 true BR112018014769A2 (pt) | 2018-12-11 |
Family
ID=55236207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018014769-9A BR112018014769A2 (pt) | 2016-01-21 | 2017-01-20 | ?composto, composição farmacêutica, e, método para tratamento do eczema nas mãos? |
Country Status (31)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3968997T3 (fi) * | 2019-05-15 | 2026-06-09 | Leo Pharma As | Delgositinibin formulaatio voiteen muodossa |
| CA3210150A1 (en) * | 2021-02-02 | 2022-08-11 | Pfizer Inc. | Dosing regime for treatment of chronic hand eczema |
| KR20240027044A (ko) * | 2021-07-30 | 2024-02-29 | 일라이 릴리 앤드 캄파니 | 바리시티닙을 사용한 손 습진의 치료 |
| JP2026509302A (ja) | 2023-03-17 | 2026-03-17 | レオ ファーマ アクティーゼルスカブ | 中等症ないし重症の慢性手湿疹を有する患者における慢性手湿疹を処置する方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI466885B (zh) | 2009-07-31 | 2015-01-01 | Japan Tobacco Inc | 含氮螺環化合物及其醫藥用途 |
| US20130302298A1 (en) * | 2010-11-30 | 2013-11-14 | Bio-K Plus International Inc. | Treatment and prevention of eczema |
| US20140343034A1 (en) * | 2013-04-25 | 2014-11-20 | Japan Tobacco Inc. | Skin barrier function improving agent |
-
2017
- 2017-01-20 ES ES17701828T patent/ES2963784T3/es active Active
- 2017-01-20 EP EP23195420.7A patent/EP4257205A3/en active Pending
- 2017-01-20 DK DK17701828.0T patent/DK3405197T3/da active
- 2017-01-20 EP EP17701828.0A patent/EP3405197B1/en active Active
- 2017-01-20 SG SG10202006830WA patent/SG10202006830WA/en unknown
- 2017-01-20 RS RS20231010A patent/RS64798B1/sr unknown
- 2017-01-20 FI FIEP17701828.0T patent/FI3405197T3/fi active
- 2017-01-20 CN CN202311350781.2A patent/CN117159553A/zh active Pending
- 2017-01-20 RU RU2018130097A patent/RU2018130097A/ru unknown
- 2017-01-20 MX MX2018008449A patent/MX394358B/es unknown
- 2017-01-20 IL IL320757A patent/IL320757A/en unknown
- 2017-01-20 KR KR1020187024112A patent/KR20180102662A/ko not_active Ceased
- 2017-01-20 CN CN201780006075.2A patent/CN108472297A/zh active Pending
- 2017-01-20 TW TW106102111A patent/TWI783921B/zh active
- 2017-01-20 PT PT177018280T patent/PT3405197T/pt unknown
- 2017-01-20 SG SG11201805394QA patent/SG11201805394QA/en unknown
- 2017-01-20 TW TW111141449A patent/TWI841027B/zh active
- 2017-01-20 IL IL313543A patent/IL313543A/en unknown
- 2017-01-20 BR BR112018014769-9A patent/BR112018014769A2/pt not_active Application Discontinuation
- 2017-01-20 SI SI201731440T patent/SI3405197T1/sl unknown
- 2017-01-20 HR HRP20231448TT patent/HRP20231448T1/hr unknown
- 2017-01-20 HU HUE17701828A patent/HUE064192T2/hu unknown
- 2017-01-20 LT LTEPPCT/EP2017/051133T patent/LT3405197T/lt unknown
- 2017-01-20 AU AU2017209932A patent/AU2017209932A1/en not_active Abandoned
- 2017-01-20 JP JP2018538167A patent/JP6929860B2/ja active Active
- 2017-01-20 SM SM20230415T patent/SMT202300415T1/it unknown
- 2017-01-20 KR KR1020257019206A patent/KR20250088666A/ko active Pending
- 2017-01-20 CA CA3010547A patent/CA3010547A1/en active Pending
- 2017-01-20 US US16/071,209 patent/US20200397787A1/en not_active Abandoned
- 2017-01-20 PL PL17701828.0T patent/PL3405197T3/pl unknown
- 2017-01-20 IL IL297379A patent/IL297379A/en unknown
- 2017-01-20 WO PCT/EP2017/051133 patent/WO2017125523A1/en not_active Ceased
- 2017-01-20 UA UAA201808829A patent/UA123780C2/uk unknown
- 2017-01-20 CN CN202311350784.6A patent/CN117159554A/zh active Pending
-
2018
- 2018-06-18 IL IL260094A patent/IL260094A/en unknown
- 2018-06-19 ZA ZA2018/04098A patent/ZA201804098B/en unknown
- 2018-07-09 MX MX2022005915A patent/MX2022005915A/es unknown
-
2022
- 2022-07-08 US US17/811,347 patent/US20230138114A1/en not_active Abandoned
- 2022-10-13 AU AU2022252766A patent/AU2022252766B2/en active Active
-
2023
- 2023-11-10 CY CY20231100643T patent/CY1126388T1/el unknown
-
2024
- 2024-11-28 AU AU2024266962A patent/AU2024266962A1/en active Pending
- 2024-12-13 NO NO2024058C patent/NO2024058I1/no unknown
- 2024-12-13 NL NL301306C patent/NL301306I2/nl unknown
- 2024-12-15 FR FR24C1053C patent/FR24C1053I2/fr active Active
- 2024-12-17 CY CY2024037C patent/CY2024037I2/el unknown
- 2024-12-17 HU HUS2400045C patent/HUS2400045I1/hu unknown
- 2024-12-17 LT LTPA2024538C patent/LTPA2024538I1/lt unknown
- 2024-12-19 FI FIC20240048C patent/FIC20240048I1/fi unknown
-
2026
- 2026-01-16 US US19/451,254 patent/US20260216193A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017001035A2 (es) | “2-(morfolin-4-il)-1,7-naftiridinas sustituidas, composiciones y combinaciones farmacéuticas que las comprenden, y compuestos intermediarios | |
| MX2019005379A (es) | Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo. | |
| BR112017006113A8 (pt) | usos de auristatina, composições farmacêuticas, formas de dosagem para o tratamento de câncer e kits. | |
| BR112015023922A2 (pt) | composição farmacêutica compreendendo um ativador de ampk e um agente serotonérgico e métodos de uso destes | |
| CL2016000313A1 (es) | Compuestos de benzoxaborol tricíclicos y usos de los mismos | |
| NI201500118A (es) | Imidazopiridazinas sustituidas | |
| CU20200008A7 (es) | Compuestos de dihidrooxadiazinonas sustituidas útiles en el tratamiento de enfermedades hiperproliferativas, métodos para preparar dichos compuestos y composiciones farmacéuticas que los contienen | |
| BR112015027440A2 (pt) | DERIVADO DE [1,2,4]TRIAZOL[4,3-a]PIRIDINA, MÉTODO DE PREPA-RAÇÃO OU APLICAÇÃO MÉDICA DO DERIVADO | |
| UY37973A (es) | Derivados de indol macrocíclicos | |
| UY37250A (es) | Derivados macrocíclicos de indol | |
| DOP2016000007A (es) | Pirazolpiridinas sustituidas | |
| CY1126388T1 (el) | Χρηση delgocitinib για την θεραπεια χρονιουεκζεματος χεριων | |
| BR112017004580A2 (pt) | composto, composição farmacêutica, produto de combinação, uso de um composto ou sal farmaceuticamente aceitável, e, método de tratamento. | |
| UY37972A (es) | Derivados de indol macrocíclicos sustituidos con cloro | |
| MX2019001225A (es) | Compuesto aromatico heterociclico nitrogenoso, metodo de preparacion del mismo, composicion farmaceutico del mismo y aplicacion del mismo. | |
| BR112015023078A2 (pt) | inibidores de pirrolopirimindina cdk9 quinase | |
| BR112018005771A2 (pt) | composto, agente terapêutico ou preventivo, uso de um composto, composição farmacêutica, e, método para tratamento de alopecia areata. | |
| MX2021012874A (es) | Tratamiento del lupus eritematoso cutaneo. | |
| DOP2019000099A (es) | Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y usos de los mismos | |
| BR112012027660A2 (pt) | derivados de imidazo[1,2-a]piridina | |
| BR112018012110A2 (pt) | uso de derivados duplos de di-hidroisoquinolínio para o tratamento de materiais de queratina, composições e processos de implementação | |
| BR112016024510A2 (pt) | ?medicamento, uso de brexpiprazol ou de um sal farmaceuticamente aceitável do mesmo, métodos para prevenção ou tratamento de um transtorno relacionado com substância e para produção de uma composição farmacêutica, composição farmacêutica, e, kit? | |
| PE20142020A1 (es) | Metodos para tratar el cancer usando inhibidor de pi3k e inhibidor de mek | |
| PH12017500323A1 (en) | P38 map kinase inhibiting indanyl urea compounds | |
| PY1773438A (es) | Método para producir una composición farmacéuticamente estable presentada como una solución acuosa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |